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INTRODUCTION
IT has been suggested that anti-basement membrane (BM) antibody is responsible
for the development of the pulmonary and the renal lesions in Goodpasture's syn-
drome (Sturgill and Westervelt, 1965; Beirne, et al, 1968; Willoughby and Dixon,
1970). It is a controversial issue whether this anti-BM antibody is formed by the
release of glomerular or alveolar BM antigen.
Experimental models resembling Goodpasture's syndrome have been produced
in animals by the injections of anti-lung antiserum (Hogadorn et al, 1969; Wil-
loughby and Dixon, 1970). It has also been reported that heterologous non-organ
specific antigenv (lung homogenate) can initiate an auto-immune type of glomerulo-
nephritis (Stebley and Rudofsky, 1968).
The pathogenic role of the anti-glomerular basement membrane (GBM) anti-
bodies in the production of glomerular lesion in Goodpasture's has also been
demonstrated by a successful transfer of acute glomerulonephritis to monkeys by
the intravenous injection of eluted y-globulin from patients with Goodpasture's
syndrome (Lerner et al, 1967; Lerner and Dixon, 1968b). Poskitt (1970) demon-
strated thd presence of y-globulin in the GBM of mice 24 hours after the injectio'n
of a similarly eluted y-globulin but he failed to produce a progressive glomerular
lesion. Nagi et al (1971) induced progressive glomerular and pulmonary lesions in
rats which were made proteinuric prior toi the intravenous administration of eluted
y-globulin from a case of Goodpasture's syndrome .They concluded that serum
sickness plays an important part by allowing the injected y-globulin to come in con-
tact with some component of the GBM.
The present experiment describes an attempt to induce progressive glomerulo-
nephritis in Wistar rats by intraperitoneal injections of Freund's complete adjuvant
and eluted y-globulin from the kidney of a case of Goodpasture's syndrome .
MATERIALS AND METHODS
The y-globulin was eluted from the kidney of a case of Goodpasture's syndrome
with a method used by Nagi et al (1971).
Thirty-two Wistar rats were) divided into the following three groups. Group A -
In this group 20 rats were injected by intraperitoneal route with a homogenate of
0.2 ml of the eluted y-globulinr and 0.4 ml of Freund's complete adjuvant per rat
for 6 weeks. Group B - In this group 6 rats were injected with 0.2 ml of the eluted
-,-globulin in normal saline. Group C - In this group 6 rats were injected with
Freund's adjuvant alone. The protein estimations were carried out on the 24 hour
specimens of urine at weekly intervals till the termination of the experiment at 18
weeks. Kidney and lung tissues obtained from each rat were examined by histologi-
cal, immunofluorescent and electronmicroscopical techniques.
136RESULTS
During the course of the experiments the proteinuria in the control groups (B and
C) of animals was within normal limits, whereas in the test group it showed con-
tinuously rising levels (Figure 1).
The results of immunofluorescent studies are summarised in Table I. It is evident
that no control animals had the glomerular localisation of human or rat globulins.
On the other hand, 16 of the
20 rats in Group A showed
linear localisation of auto-
200 - Group_A logous y-globulin and com-
oo s * _B plement along the GBM and
^ 2 t ._C alveolar capillary BM.
160 In the kidneys of Group
A animals moderate to
severe histologlical abnor-
120 malities were observed by
the various staining tech-
niques. From 50 to 75 per
cent. of theglomeruli in this 180 /group showed proliferation
of endothelial and mesan-
40 gial cell. Most of the glom-
eruli showed this change in
2 to 3 lobules whereas the
remainder of the lobules
4 8 12 1 6 20 appeared normal. The capil-
We e k lary lumens in many glom-





Group Rat IgG Rat BiC Human lgG Human BiC with lesions
+ -ve 4/20
A ++ 6/20 12/20 None None 16/20
+++ 9/20
++++ 1/20
B + + None None None None 0/6
B ++ None None None None 0/6
++
C ++ None None None None 0/6
137positive material which also stained for fibrin. The proximal convulted tubules
around the affected glomeruli were dilated and contained proteinaceous casts in their
lumens (Figure 2). By electron microscopy the glomerular lesions were recognised
by irregularly thickened BM and proliferation of the BM-like material towards the
........te.nd th lil.sp ct The
~~~~ ~~~~~~ ~~lumens in some of the capil-
lary loops were obliterated
with this BM-like material.
Most of the affected loops
showed subendothelial elec-
o tron dense deposits (Figures 3
and 4). The epithelial cell foot
processes were fused over the
affected loops. The tubles con-
tained numerous protein drop-
lets within their epithelial cells.
Lungs: All rats in Group-A
showed moderate degree of
*00 ; 7 lymphocytic infiltration of the
inter-alveolar speta with some
thickening of the alveolar walls.
FIG. 2. A fewdeposits of haemosiderin
Cellular prolilferation and other changes described ill were also seen in most of the
the text can be seen in part of' the glomerulus. specimens.
The control groups B and C showed none of the histological, electron or im-
munofluorescent microscopical abnormalities.
DISCUSSION
The results of the present experiment show that eluted y-globulint from the kid-
ney of a patient with Goodpasture's syndrome can initiate a disease recognised by
progressive lesions of lungs and kidneys. It is also evident that these lesions were
consistenly produced in Group-A rats which were injected with a homogenate of
the eluted y-globulin and Freund's adjuvant. Fluorescent antibody test revealed the
localisation of autologous y-globulin and complement in a focal linear distribution
along the glomerular and the alveolar capillary BM. On histological and electron
microscopical examination these lesions were similar to those described by Nagi
et al (1971).
The pathogenesis of Goodpasture's syndrome is still a controversial issue. Vari-
ous experimental models suggest that the lesions might be initiated by antibodies
directed against both lungs and kidneys or anti-GBM antibodies which cross-react
with alveoilar capillary BM. (Stebley and Rudofsky, 1968, Hagadorn et al, 1969;
Willoughby and Dixon, 1970). Lerner and Dixon (1968a) put forward the possibility
that certain "undefined associated factors must be present before the GBM-antigen
can induce glomerulonephritis". Nagi et al (1971) suggest that these undefined fac-
tors could be serum sickness induced changes in the GBM permeability and the
presence of an excessive amount of anti-GBM antibody.
138The actual mechanism by which the present experimental model is produced is
not known. We put forward a hypothesis which may elucidate the events leading to
the production of this disease. The vulnerability of the GBM is increased by the
administration of Freund's adjuvant (Heymann et al, 1962 and 1963; Watson, ,,~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~.."..........,..!410'-s^@'>
a, . IN
FIG. 3 (above)
Osmiophilic deposit along the sub-
endothelial aspect of the thickened
glomerular basement membrane in
a group-A rat. Electron micro-
graph.
FIG. 4. (left).
Another glomerular loop showing
marked proliferation of the GBM,
resulting in the obliteration of its
lumet.
BM = Basemenit mebrane
En = Endothelial cells
D deposit
Fp Foot processes
Cl - Capillary lumen
139Dixon and Feldman, 1965; Cuppage, 1965) and by serum sickness (Barabas et al,
1970; Nagi et al, 1971). Freund's adjuvant containing eluted y-glo'bulin might have
come into, contact with the nephritogenic material irn the, GBM leading to its intra-
vascular release and the production of autoantibodies. These autoantibodies might
have started a cycle oiE events which maintained the release of the GBM antigens
and the formation of autoantibodies which might result in the type of tissue damage
observed in the lungs and kidneys of these rats. Autoantibodies formed against the
GBM might have cross-reacted with the alveolar capillary BM resulting in the dual
lesions in this disease. In view of this observation it is suggested that in addition
to serum sickness certain factors (Freund's adjuvant in this case) which increase
the vulnerability of the, BM may also, help in initiating an event responsible for the
production of a progressive disease) of this nature.
SUMMARY
A progressive glomerulonephritis and pulmonary lesion have been produced in
Wistar ratsl using a homogenate of eluted y-globulin from a case of Goodpasture's
syndrome, and Freund's complete adjuvant. It is suggested that the Freund's adju-
vant-induced changes in the vulnerability of the GBM may contribute to the
initiation of an autoimmune cycle which may lead to the production of a, progres-
sive disease of the BM.
My thanks are due to Professor Sir J .H. Biggart, C.B.E., for his advice, Messrs. W. Kirk-
wood, P., Westwood and S. Cameron for their technical help, and Mr. D. Mahaffy for the
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